phenotypes may provide clues regarding the pathogenesis and prevention of subsequent asthma. Reference 1. Holt PG, Strickland D, Bosco A, Belgrave D, Hales B, Simpson A, et al. Distinguishing benign from pathologic TH2 immunity in atopic children.
The odds ratio (OR) of a diagnosis of MMA where sIgE to alpha-gal is positive is only 2.5 (95% CI 0.7-8.6, P = 0.16). The OR of the presence of atopy is 1.3 (95% CI 0.5-3.3, P = 0.64). However, the OR for a history of tick bite is 15.4 (95% CI 5.3-45.3, P < 0.001).
Conclusions: sIgE to alpha-gal does not add any further information to clinical history in the diagnosis of MMA. It only confirms that the patient has had a tick bite (in our population by Ixodes holocyclus). In our experience, this can be ascertained by the individual or at a clinical review. A reduction in the number of assays to sIgE to alpha-gal performed would reduce costs to these tick-endemic communities. Objectives: The purpose of the study was to describe the food allergy profile and determine feeding disorder and faltering growth rates in 0-24 month old food allergic children newly presenting to a tertiary Allergy clinic in Southern Adelaide.
Methodology: A 12-month single centre retrospective case note review was conducted for all children aged 0-24 months, attending their initial Allergy clinic appointment from 1 July 2011 to 30 June 2012. Data was collected on food allergy clinical characteristics as well as anthropometric data for birth, initial appointment and 24 months of age to determine growth trajectory. A fall through 2 or more World Health Organisation percentile lines from birth for one or more anthropometric measures defined faltering growth for our cohort.
Results: Food allergies included egg, peanut, cow's milk protein, present in 62 (67%), 47 (51%) and 45 (49%) respectively. Allergies were exclusively IgE mediated in 54 (59%) and purely non-IgE mediated in 14 (15%); 24 (26%) had concurrent IgE and non-IgE mediated food allergies. 81 (90%) experienced chronic food allergy and atopy related symptoms. Feeding disorders were identified in 20 (22%). Faltering growth was evident in 25 (27%) at initial appointment, which resolved following clinical intervention in 10 (77%) of 13 children measured at 24 months of age.
Conclusions: Chronic food allergy and atopy associated symptoms were almost universal, indicating substantial disease burden. Feeding disorders and faltering growth were both common and we recommend all infants with food allergy to be regarded as vulnerable and receive proactive assessment and intervention for these complications of food allergy. In 2011, the Health Nuts study revealed '10.5% of Melbourne Children have challenge proven food allergy' (Allen, K. JACI 2011)
Aim: The aim was to perform an up to date audit of challenge provision in the setting of a highly food allergy susceptible population.
Method: A retrospective data base review of all paediatric challenges was performed over a 12 month period from May 2016 to April 2017.
The purpose of this audit was to determine:
• Total number of challenges performed • Types of challenges performed • Rates of positive/negative/inconclusive challenge outcomes • Anaphylaxis rate of challenges • Age at time of challenge Results: The number of outpatients seen generated 1664 challenges per year for the Allergy Care area, a nurse led unit located within Day Medical Care.
Of these, 86% were food challenges, 9% were drug challenges and 5% other (latex, exercise, vaccine and intradermal testing) with a rate of positive challenges of 16%, anaphylaxis of 1% of all challenges and 8% of all positive oral food challenges. The median age of patients was 7.9 years.
Conclusion: This data enables us to continue to develop allergy services to satisfy current demand and to plan for future needs in this evolving allergy population. Paediatric food allergy practice requires access to an observed food challenge (OFC), the gold standard investigative tool. This process requires supervision by trained health professionals experienced in management of acute allergic reactions, including anaphylaxis. In New Zealand, OFCs are done in both a tertiary care paediatric center (Starship Children's Hospital -SCH) as well as numerous regional paediatric sites. We present the prospective data obtained from food challenges undertaken in an 18-month period from September 2015 to March 2017.
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Methods: Food challenges were conducted at 6 regional paediatric centers across the North and South Island and at SCH, Auckland. Decision for OFC was made by the treating physician and based on history and testing for food specific IgE (skin prick and/or serum specific IgE). Open label food challenge protocols were standardised to the ASCIA guidelines where possible and published 'stop' criteria were employed. Data was prospectively obtained, deidentified, compiled and analysed at the end of the study period. Results: During the 18-month study period 1104 children underwent OFC. Forty three percent of the challenges (473) were conducted at SCH. There was no significant difference between the rates of OFC clinical reaction at SCH (113/473 -24%) compared to the regional sites, independently or combined, with an average reaction rate of 24% (range 13-31%).
Anaphylaxis was seen at all but one site. This occurred in 14% of those that reacted at SCH (16/113) and at an average of 16% (24/154) in regional children (range 0-23%).
Conclusion: Paediatricians and experienced allied health professionals are able to successfully and safely undertake OFC for children in regional areas with outcomes that replicate those in a tertiary centre. This reduces travel costs, public expenditure and tertiary waitlists while maintaining optimum allergy care provision. Objective: To determine if a targeted education program to Emergency Department staff leads to improved management of paediatric anaphylaxis within the department and at discharge.
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Methods: A retrospective review of the electronic records of all paediatric presentations to the emergency department at a large regional centre over a 3-year period was performed on entries containing final diagnoses terms of anaphylaxis, allergy unspecified, dermatitis due to ingested food, food reaction non-dermatitis, urticaria and vaccine complication. Targeted education was introduced at 12-and 18-months during the 3-year study period consisting of a single, 40-min audio-visual presentation by paediatric staff to Emergency Department staff.
Results: In the first 12 months prior to targeted education, 17 patients fulfilled the Australasian Society of Clinical Immunology and Allergy (ASCIA) clinical diagnostic criteria for anaphylaxis. 8 patients (47%) were given an alternative, less serious, diagnosis. Only 4 patients (40%) were given adrenalin in the emergency department. At discharge, only 2 patients (20%) were given EpiPen ® prescription with no documented training; 1 patient (10%) received an anaphylaxis management plan and none were referred to an allergy specialist. Following the targeted education program, 22 patients fulfilled ASCIA clinical diagnostic criteria for anaphylaxis. 9 patients (43%) were given an alternative, less serious, diagnosis. The appropriate use of adrenalin increased by 21%. At discharge, the supply of an EpiPen R prescription with documented training increased by 19%; the supply of an anaphylaxis management plan increased by 16% and referral to an allergy specialist increased by 33%.
Conclusion: Targeted education with minimal time and specialist knowledge requirements to Emergency Department staff improves management of paediatric anaphylaxis within the department and at discharge. Background: Recent studies based on hospital admissions have reported a significant increase of anaphylaxis prevalence. These studies rely on accurate diagnosis and coding data from medical records, which has been identified as a potential shortcoming. The aim of this study was to investigate the extent of anaphylaxis miscoding, how this changed after intensified training programs and new anaphylaxis guidelines, and whether this contributed to apparent changes in prevalence over a 10-year period.
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Methods: We conducted a retrospective chart examination of all cases coded as anaphylaxis presenting to the main tertiary Pediatric Emergency Department (PED) in Perth, Australia. We compared data from 2003/ 2004 with data from 2012, after intensified training programs and new anaphylaxis guidelines were introduced. Information was collected on standardised forms. : 136/83832 ED presentations in 2003 /2004 and 177/71822 ED presentations in 2012 were coded as anaphylaxis (ICD-10) with significantly more coding errors in 2003/2004 (44/136;32%) than in 2012 (18/177;10%) .
Results
A diagnosis of anaphylaxis was verified in 92/136 (68%) cases in 2003/ 2004 and 159/177 (90%) cases in 2012, indicating a two-fold increase in presentations with anaphylaxis (P < 0.001). Sub-analysis suggested that infants between 12 and 24 months showed the largest (5-fold) increase (0.54/1000 in 2003 compared to 2.69/1000 in 2012). An increase in food allergy was the main contributing factor (P < 0.001) largely from tree-nut allergies.
We also examined for potential under-diagnosis of anaphylaxis analyzing 400 randomly selected cases of ED presentations attributed to conditions with an associated diagnosis.
Based on the estimate of total anaphylaxis cases for both time periods we found an under-diagnosis rate of 37% (63% correctly diagnosed) in 2003/ 2004 and 20% (80% correctly diagnosed) in 2012.
Conclusion:
To our knowledge this is the first study to examine changing patterns of emergency presentations of paediatric anaphylaxis in the context of coding errors. Comparing the years 2003/2004 and 2012 the rate of accurate coding improved which is crucial for the evaluation of epidemiological trends, adequate education/guidance of primary care takers and reduction of costs in the health care system. This could be achieved by improving collaborations between Pediatric Allergists and Emergency Physicians, reinforcing guidelines and training programs.
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Introduction: As the initial cohort from Australia's 'allergic epidemic' reaches adulthood the prevalence of adolescents with food allergy (FA) is rising and placing increasing burden on the healthcare system. This project reflects on current practice and offers potential solutions to improve management and aid transition to adult health services.
Method: A clinical service redesign project conducted at the Immunology department of Princess Margaret Hospital, Western Australia. There were several stages and input from staff, patients and their families.
Results: Families remained focused on the hope of outgrowing FA despite available literature suggesting this was extremely unlikely in adolescence. A major contributing factor was clinic structure with a focus on skin prick testing (SPT) and long wait periods. The inefficient use of time missed opportunities to improve health knowledge and practice. This was reflected in patient/parent surveys; families reported minimal teaching from health professionals regarding reading food labels and/or EpiPen training. Worryingly most adolescents reported teaching from parents alone. There was a significant discrepancy between patient confidence reading food labels and parent confidence in their child's ability. In addition, the majority of adolescents reported poor EpiPen carriage. In response to these concerns a pilot clinic was devised with a focus on group teaching by dieticians and specialist nursing staff. A research Q&A was 
